|
A lot depends
on the patient's constitution, the grade of his disease and its staging.
Patients are usually treated by a team of specialists which utilizes
a multipronged approach. This includes an hematologist, a medical
oncologist and a radiotherapist.
The plan of treatment is tailored to fit a patient's requirements.
Treatment strategies.
Unlike the common public perception, most leukaemias have some sort
of treatment. This applies for ALL as well. The bastion of treatment
for ALL is chemotherapy.
Radiation may also be used in certain cases. And
bone marrow
transplant is always an option, which is to be kept in the
mind.
The best attempt to control leukaemia cancer cells circulating in
the body and lodged at various places is by using systemic
therapy (therapy which affects the entire systems of the body)
which is in the form of injections or oral drugs. This form of treatment
is called chemotherapy.
This form of treatment is given in a cyclical manner (each set of
drugs is repeated usually after every 3-4 weeks).
Chemotherapy can also be used in combination with surgery, radiotherapy
or both, either before or after.
Radiation therapy
involves the use of high energy, penetrative rays to destroy cancer
cells. It affects cancer cells only in the zone treated. Radiation
therapy is also employed for palliation i.e. control
of symptoms alone in an advanced cancer.
Radiation therapy can also be used in adjunct to surgery or chemotherapy,
either before or after.
Teletherapy or external radiation is given via
a machine remote from the body while brachytherapy or internal radiation
is given by implanting a radioactive source within the involved tissues.
Patients may or may not require both modalities of radiation.
Radiotherapy, after initial planning, usually takes just 5 to 10 minutes
per day, 5 days a week for about 6 weeks. This time period is flexible
depending upon the modality of radiation used.
There are basically two phases of treatment for ALL. The first stage
is known as induction. The purpose of induction
is to destroy as many of the leukaemia cells as possible and put the
patients into the remission state.
Once in remission with no clinical signs of leukaemia, patients enter
the second part of the treatment, which is called continuation
or maintenance therapy. It is also sometimes known
as consolidation therapy. This tries to kill any
remaining leukaemia cells, which may be subclinical or just below
the detectable margins.
A patient may have to receive chemotherapy for up to several years
to stay in comfortable remission.
The patient will also have to receive radiation or chemotherapy for
the brain. This is known as cranial prophylaxis.
This is for several reasons: |
|
 |
To prevent leukaemia cells
from growing into the brain during induction therapy and remission. |
 |
For those patients who have
already got leukemia cells detected in the brain. |
Bone
marrow transplantation is an option in which the entire bone
marrow of the patient is replaced with healthy bone marrow.
First of all the bone marrow in the body is destroyed with high-dose
chemotherapy in association or without radiation therapy.
The healthy bone marrow is then taken from another person whose tissue
has the same HLA matching as the patient's. HLA
is a kind of tissue matching, which is required to be done before
any kind of tissue is transferred from a donor to a recipient in order
to prevent a reaction and the donor's body from rejecting the entire
tissue sample.
The donor may be an identical twin, which always produces the best
match, or a sibling such as a brother or sister, or a totally unrelated
person. The healthy marrow from the donor is given to a patient just
like saline, that is, through a needle in the vein and the marrow
replaces the marrow that has been destroyed.
A bone marrow transplant or a BMT using marrow from a relative or
person not related to the patient is called an allogenic
BMT.
Autologous BMT is a type of transplant in which the bone marrow
is taken from the patient before radical chemotherapy, and then is
treated with drugs to kill any cancer cells. Then the marrow is cryogenically
frozen to save it, and high-dose chemotherapy is given with or without
radiation to the patient to destroy the remaining marrow. The frozen
marrow is now thawed out and reintroduced into the patient through
a needle in a vein.
Maximum chances for recovery occur if the doctor chooses a hospital
that has done a significant number of BMTs with very less evidence
of either septicemia, infection, or rejection.
Yet another type of autologous transplant is called a peripheral
blood stem cell rescue transplant. In this, the patient's blood
is passed through a machine that removes the immature cells from which
all blood cells develop (the stem cells) and then
returns the blood to the patient. This procedure, known as leukapheresis,
usually takes 3 to 4 hours to complete.
The stem cells are now treated with drugs to kill any cancer ingredient
in them and are then cryogenically frozen until they can be transplanted
to the patient. This may be done in association or disassociated from
an autologous bone marrow transplant.
For AML, the other option which is present is biological
therapy, which tries to induce the body to fight the cancerous
cells by harnessing, redirecting and amplifying the body's immunity
and infection-fighting ability and also by increasing and augmenting
its natural defenses against disease. Biological therapy is also known
as immunotherapy
or BRM, that is biological response
modifier therapy.
Untreated adult acute lymphoblastic leukaemia
The treatment is going to be: |
 |
Systemic chemotherapy along
with intrathecal chemotherapy alone, or combined with either radiation
therapy to the brain or high doses of systemic chemotherapy to prevent
or treat leukaemia in the brain. |
| The treatment
as an adjunct will also include: |
 |
Repeated blood transfusions. |
 |
Antibiotics. |
 |
Fresh frozen plasma infusions. |
 |
Packed cell volume infusions. |
 |
Instructions to keep the body
and feet especially clean. |
| Continuously,
new drugs are being tested in clinical trials. |
| Recurrent
adult acute myeloid leukaemia. |
 |
Systemic chemotherapy along
with intrathecal chemotherapy alone, or combined with either radiation
therapy to the brain or high doses of systemic chemotherapy to prevent
or treat leukaemia in the brain. |
| The treatment
as an adjunct will also include: |
 |
Repeated blood transfusions. |
 |
Antibiotics. |
 |
Fresh frozen plasma infusions. |
 |
Packed cell volume infusions. |
 |
Instructions to keep the body
and feet especially clean. |
Continuously,
new drugs are being tested in clinical trials.
ALL in remission |
 |
Short-term, high-dose chemotherapy
followed by long-term, low-dose chemotherapy as consolidation. |
 |
Allogenic bone marrow transplant. |
 |
Autologous bone marrow transplant. |
 |
Intrathecal chemotherapy (chemotherapy
given by lumbar puncture into the brain and spinal cord area combined
with either radiation to the brain or high doses of systemic chemotherapy).
This is to prevent leukaemia cells from growing in the brain and the
spinal cord area, otherwise known as CNS or cranial prophylaxis. |
| Recurrent
adult acute lymphocytic leukaemia |
 |
Radiation therapy to palliate
symptoms. |
 |
Patients may also get a trial
of bone marrow transplant. |
Untreated
adult acute myeloid leukaemia is usually treated by systemic multi-drug
chemotherapy. The person also may get CNS prophylaxis and, in case
leukaemia cells are found in the brain, chemotherapy may be given
intrathecally anyway.
Adult acute myeloid leukaemia in remission.
Treatment will most likely be: |
 |
Systemic chemotherapy and
including experimental new drugs. |
 |
A clinical trial evaluating
BMT versus peripheral stem cell rescue. |
| Recurrent
adult acute myeloid leukaemia. |
 |
Radiotherapy plus trial chemotherapy. |
 |
Bone marrow transplant.
|